Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
RGFP966 (3 or 10 mg/kg
it has been used for many years
Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects
PD173074 is a small-molecule FGFR3-selective tyrosine kinase inhibitor (TKI)
Riveros-Rosas H
KDM4B-IN-B3 Size:Contact [email protected] for quotation RGFP966 (3 or 10 mg/kgKDM4B IN B3, also know as NCGC00244536, is a novel KDM4 inhibitor. KDM4B IN B3 inhibits the in vivo growth of tumors derived from PC3 cells and ex vivo human PCa explants. Histone lysine demethylase KDM4 JMJD2s are overexpressed in many human tumors including prostate cancer (PCa). Product information CAS Number: 2003260 55 5 Molecular Weight: 382. 45 Formula: C25H22N2O2 Synonym: NCGC00244536 Chemical Name: 3 (8 Hydroxyquinolin 6 yl) N (3
US$ 20.00
US$ 22.00
US$ 64.58